World first drug to target previously untreatable life-threatening form of ‘bad cholesterol’
A new drug offers a breakthrough world-first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke. Professor Stephen Nicholls, Director of the Victorian Heart Hospital and Monash...